Childhood Cancer

You are here

All grants tagged with "Acute Myeloid Leukemia (AML)"

Clinical Translation of Off the Shelf CLL1 Targeted CAR-Vd2 T Cells for AML

Norihiro Watanabe, PhD

Baylor College of Medicine

Reach Grants, Awarded 2026

Development of Programmable RNA Sensors to Treat Pediatric Oncofusion Cancers

Alan Cantor, MD/PhD

Boston Children’s Hospital

Reach Grants, Awarded 2026

Neoantigen-specific T cells for CBFA2T3-GLIS2 driven pediatric acute megakaryoblastic leukemia

Tanja Gruber, MD/PhD

Board of Trustees of the Leland Stanford Junior University

Innovation Grants, Awarded 2026

Mechanisms and Therapeutic Targets of UBTF Tandem Duplication in Pediatric Acute Myeloid Leukemia

Mingjun Liu, PhD

New York University School of Medicine

Young Investigator Grants, Awarded 2026

Targeting KAT2A-Dependent Oncogenic Transcriptional Programs in Pediatric AML Using a Novel Molecular Glue Degrader

Alba Sommerschield, MD

Dana-Farber Cancer Institute

Young Investigator Grants, Awarded 2026

The NRAS palmitoylation cycle as a therapeutic target in pediatric leukemia

Matthew Decker, MD/PhD

University of California San Francisco

Young Investigator Grants, Awarded 2026

Optimizing CD33-Targeted Antibody-Drug Conjugate Therapy for Acute Myeloid Leukemia

Margery Gang, MD

Fred Hutchinson Cancer Research Center

Young Investigator Grants, Awarded 2026

Targeting WT1-Mutant Stem-like Programs Driving Lineage Plasticity and Therapy Resistance in Pediatric AML

Ke Wang, PhD

Icahn School of Medicine at Mount Sinai

Young Investigator Grants, Awarded 2026

Modeling Clonal Hematopoiesis and Genetic Correction in RUNX1-FPD Using Human iPSC-derived HSCs

Eirini Papapetrou, MD/PhD

Icahn School of Medicine at Mount Sinai

RARE Grant Program (Research Accelerating RUNX1 Exploration), Awarded 2026

Clinical effectiveness data for the “AML Care at Home” implementation-effectiveness trial

Vaanya Salwan

Children’s Hospital of Philadelphia

POST Program Grants, Awarded 2026

Pages

All childhood cancer types